Corindus Vascular Earnings


Corindus reported their 2Q earnings:


  • Revenue: $2.3m
  • 10 more additional units installations before year’s end
  • PRECISION GRX Registry – market surveillance

Guidance remained the same, expecting $13 – 15m EOY.

Corindus has roughly $35m in cash with a $8m burn rate per quarter, and with more installations of machines.

I’m a huge believer in this machine, and I think it’s a great long term hold. ¬†This ER just proved that the company is turning itself now and this shows great opportunity.

You can read my due diligence about this company here.

Disclosure: I have a large long position in this company since February 2017.